IL6 and diabetic retinopathy: Additionally, in models of diabetic retinopathy, UA reduced inflammation (IL-6, IL-1β, TNF-α) and oxidative stress by increasing levels of SOD and GSH while decreasing MDA, effects associated with activation of the Nrf2/HO-1 pathway [58].